698 related articles for article (PubMed ID: 26714944)
21. Role of ICG-
Paredes P; Vidal-Sicart S; Campos F; Tapias A; Sánchez N; Martínez S; Carballo L; Pahisa J; Torné A; Ordi J; Carmona F; Lomeña F
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1853-1861. PubMed ID: 28492965
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue.
Papadia A; Gasparri ML; Buda A; Mueller MD
J Cancer Res Clin Oncol; 2017 Oct; 143(10):2039-2048. PubMed ID: 28828528
[TBL] [Abstract][Full Text] [Related]
23. A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer.
Holloway RW; Ahmad S; Kendrick JE; Bigsby GE; Brudie LA; Ghurani GB; Stavitzski NM; Gise JL; Ingersoll SB; Pepe JW
Ann Surg Oncol; 2017 Jul; 24(7):1972-1979. PubMed ID: 28265777
[TBL] [Abstract][Full Text] [Related]
24. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
Foster D; Choy N; Porter C; Ahmed S; Wapnir I
J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
[TBL] [Abstract][Full Text] [Related]
25. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
[TBL] [Abstract][Full Text] [Related]
26. Fluorescent-guided surgery and the use of indocyanine green sentinel lymph node mapping in the pediatric and young adult oncology population.
Johnston ME; Farooqui ZA; Nagarajan R; Pressey JG; Turpin B; Dasgupta R
Cancer; 2023 Dec; 129(24):3962-3970. PubMed ID: 37740680
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node detection using 99mTc combined with methylene blue cervical injection for endometrial cancer surgical management: a prospective study.
López-De la Manzanara Cano C; Cordero García JM; Martín-Francisco C; Pascual-Ramírez J; Parra CP; Céspedes Casas C
Int J Gynecol Cancer; 2014 Jul; 24(6):1048-53. PubMed ID: 24927249
[TBL] [Abstract][Full Text] [Related]
28. Optimizing Strategies for Sentinel Lymph Node Mapping in Early-Stage Cervical and Endometrial Cancer: Comparison of Real-Time Fluorescence With Indocyanine Green and Methylene Blue.
Buda A; Di Martino G; Vecchione F; Bussi B; Dell'Anna T; Palazzi S; Cantù MG; Marchette MD; Milani R
Int J Gynecol Cancer; 2015 Oct; 25(8):1513-8. PubMed ID: 26397069
[TBL] [Abstract][Full Text] [Related]
29. Utilization of Indocyanine Green to Aid in Identifying Sentinel Lymph Nodes in Merkel Cell Cancer.
Knackstedt RW; Knackstedt T; Gastman B
J Surg Res; 2018 Dec; 232():365-368. PubMed ID: 30463742
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymphadenectomy in cervical cancer using near infrared fluorescence from indocyanine green combined with technetium-99m-nanocolloid.
Soergel P; Kirschke J; Klapdor R; Derlin T; Hillemanns P; Hertel H
Lasers Surg Med; 2018 Dec; 50(10):994-1001. PubMed ID: 29968916
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node mapping with indocyanine green compared to blue dye tracer in gynecologic malignancies-A single center experience of 218 patients.
Pölcher M; Matz S; Braun M; Brambs C; Beer M; Hamann M
J Surg Oncol; 2021 Mar; 123(4):1092-1098. PubMed ID: 33333589
[TBL] [Abstract][Full Text] [Related]
32. The Added Value of SPECT/CT in Sentinel Lymph Nodes Mapping for Endometrial Carcinoma.
Naaman Y; Pinkas L; Roitman S; Ikher S; Oustinov N; Vaisbuch E; Yachnin A; Ben-Arie A
Ann Surg Oncol; 2016 Feb; 23(2):450-5. PubMed ID: 26438438
[TBL] [Abstract][Full Text] [Related]
33. Indocyanine green guidance for combined robotic pelvic and para-aortic sentinel node mapping in cervical cancer.
Van Trappen P
Surg Oncol; 2022 May; 41():101745. PubMed ID: 35358912
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.
Papadia A; Imboden S; Siegenthaler F; Gasparri ML; Mohr S; Lanz S; Mueller MD
Ann Surg Oncol; 2016 Jul; 23(7):2206-11. PubMed ID: 26790667
[TBL] [Abstract][Full Text] [Related]
35. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure.
Eoh KJ; Lee YJ; Kim HS; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Surg Oncol; 2018 Sep; 27(3):514-519. PubMed ID: 30217312
[TBL] [Abstract][Full Text] [Related]
36. Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment.
Kessous R; How J; Abitbol J; Puzhakkal S; Kogan L; Yasmeen A; Salvador S; Gotlieb WH; Lau S
Int J Gynecol Cancer; 2019 Sep; 29(7):1121-1125. PubMed ID: 31320490
[TBL] [Abstract][Full Text] [Related]
37. Sentinel Lymph Node Procedure in Pediatric Patients with Melanoma, Squamous Cell Carcinoma, or Sarcoma Using Near-Infrared Fluorescence Imaging with Indocyanine Green: A Feasibility Trial.
Jeremiasse B; van Scheltinga CEJT; Smeele LE; Tolboom N; Wijnen MHWA; van der Steeg AFW
Ann Surg Oncol; 2023 Apr; 30(4):2391-2398. PubMed ID: 36641516
[TBL] [Abstract][Full Text] [Related]
38. Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer - a randomized controlled trial.
Deken MM; van Doorn HC; Verver D; Boogerd LSF; de Valk KS; Rietbergen DDD; van Poelgeest MIE; de Kroon CD; Beltman JJ; van Leeuwen FWB; Putter H; Braak JPBM; de Geus-Oei LF; van de Velde CJH; Burggraaf J; Vahrmeijer AL; Gaarenstroom KN
Gynecol Oncol; 2020 Dec; 159(3):672-680. PubMed ID: 33041071
[TBL] [Abstract][Full Text] [Related]
39. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
[TBL] [Abstract][Full Text] [Related]
40. Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer.
Rozenholc A; Samouelian V; Warkus T; Gauthier P; Provencher D; Sauthier P; Gauthier F; Drakopoulos P; Cormier B
Gynecol Oncol; 2019 Jun; 153(3):500-504. PubMed ID: 30902369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
